Y., Tobin, C., & Schulte, T
Tirzepatide stimulates insulin secretion through the GIPR in human islets from healthy donors, supporting a role for GIPR agonism in its pharmacology (56)
Still, it once again demonstrates the potential for help that repurposed drugs, many of which have never been considered for these diseases, hold Indeed, weve seen an explosion of potential treatments (oxaloacetate, Rapamycin, nicotine patch, metformin, methylene blue, Abilify, stellate ganglion blocks, plasmapheresis, checkpoint inhibitors, Jak-Stat inhibitors, monoclonal antibodies, neuroplasticity approaches, etc.) since the advent of long COVID
Food Bioscience
Retrieved June 15, 2021 from Food and Drug Administration (FDA)